SorLA (SORL1) Human shRNA Plasmid Kit (Locus ID 6653)
CAT#: TL309181
SORL1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 2 publications. |
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | SorLA (SORL1) Human shRNA Plasmid Kit (Locus ID 6653) |
Locus ID | 6653 |
UniProt ID | Q92673 |
Synonyms | C11orf32; gp250; LR11; LRP9; SORLA; SorLA-1 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | SORL1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 6653). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_003105, NM_003105.1, NM_003105.2, NM_003105.3, NM_003105.4, NM_003105.5, BC032903, BC040643, BC137171, NM_003105.6 |
Summary | This gene encodes a mosaic protein that belongs to at least two families: the vacuolar protein sorting 10 (VPS10) domain-containing receptor family, and the low density lipoprotein receptor (LDLR) family. The encoded protein also contains fibronectin type III repeats and an epidermal growth factor repeat. The encoded preproprotein is proteolytically processed to generate the mature receptor, which likely plays roles in endocytosis and sorting. Mutations in this gene may be associated with Alzheimer's disease. [provided by RefSeq, Feb 2016] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
,Pietilä, M;Sahgal, P;Peuhu, E;Jäntti, NZ;Paatero, I;Närvä, E;Al-Akhrass, H;Lilja, J;Georgiadou, M;Andersen, OM;Padzik, A;Sihto, H;Joensuu, H;Blomqvist, M;Saarinen, I;Boström, PJ;Taimen, P;Ivaska, J;,
Nat Commun
,PubMed ID 31138794
[SORL1]
|
SORLA-driven endosomal trafficking regulates the oncogenic fitness of HER2
,Pietila, M;Sahgal, P;Peuhu, E;Jantti, N;Paatero, I;Andersen, O;Padzik, A;Blomqvist, M;Saarinen, I;Bostrom, P;Taimen, P;Ivaska, J;,
bioRxiv
[SORL1]
|
Documents
Product Manuals |
FAQs |
SDS |